Less is More: Integrating Deprescribing in the Inpatient Setting

<p>Joseph C. Osborne III, PharmD (<a href='https://twitter.com/JOzempic'>@JOzempic</a>) describes the current framework of deprescribing, reviews literature pertinent to deprescribing in the inpatient setting and identifies facilitators, barriers, and future directions for deprescribing.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>